Skip to main content

Advertisement

Log in

The association of the decline in glomerular filtration rate with aggressive endometrial cancers

  • Nephrology - Original Paper
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Purpose

Most site-specific cancer incidence is increased with the decrease of glomerular filtration rate (GFR). We analyzed endometrial cancers depending on different type, staging, and histology grades. We hypothesized that patients with lower GFR levels have an increased risk for higher staging and histology grades of endometrial cancers.

Methods

Patients were divided into two subgroups regarding GFR; the first group with GFR < 60 ml/min and the second group with GFR > 60 ml/min and regarding different histology grades and cancer stages. Cancers were also divided by stages (1–4). Patients were followed up during 1 year through regular controls in the outpatient clinic and during that time cancer recurrence was recorded.

Results

GFR was the strongest predictor for higher cancer histology grade and higher cancer staging. Patients with reduced GFR had OR for higher histology grade and higher staging of 1.06 and 1.06. Traditional risk factors for endometrial cancer development were not associated with higher histology grade or higher cancer staging.

Conclusion

Higher staging and histology grades in patients with endometrial cancers are associated with reduced GFR. Patients with mild-to-moderate CKD had significantly higher number of cancers with higher histology grades and higher stages than patients with mild or normal GFR category. Decline in GFR was independently associated with more aggressive cancers without other well-known risk factors for endometrial cancer development like age, menopause, diabetes, and obesity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Weng PH, Hung KY, Huang H et al (2011) Cancer-specific mortality in chronic kidney disease: longitudinal follow-up of a large cohort. Clin J Am Soc Nephrol 6(5):1121–1128

    Article  Google Scholar 

  2. Maisonneuve P, Agodoa L, Gellert R et al (1999) Cancer in patients on dialysis for end-stage renal disease: an International Collaborative Study. Lancet 354:93–99

    Article  CAS  Google Scholar 

  3. Cengiz K (2002) Increased incidence of neoplasia in chronic renal failure (20-year experience). Int Urol Nephrol 33:121–126

    Article  Google Scholar 

  4. Dalrymple LS, Katz R, Kestenbaum B et al (2011) Chronic kidney disease and the risk of end-stage renal disease versus death. J Gen Intern Med 26(4):379–385

    Article  Google Scholar 

  5. Iff S, Craig JC, Turner R et al (2014) Reduced estimated GFR and cancer mortality. Am J Kidney Dis 63(1):23–30

    Article  Google Scholar 

  6. Fried LF, Katz R, Sarnak MJ et al (2005) Kidney function as a predictor of noncardiovascular mortality. J Am Soc Nephrol 16(12):3728–3735

    Article  CAS  Google Scholar 

  7. Yang Y, Li H, Zhou Q et al (2016) Renal function and all-cause mortality risk among cancer patients. Medicine (Baltimore) 95(20):e3728

    Article  Google Scholar 

  8. Kato S, Chmielewski M, Honda H et al (2008) Aspects of immune dysfunction in end-stage renal disease. Clin J Am Soc Nephrol 3(5):1526–1533

    Article  Google Scholar 

  9. Reuter S, Gupta SC, Chaturvedi MM et al (2010) Oxidative stress, inflammation, and cancer. How are they linked? Free Radic Biol Med 49(11):1603–1616

    Article  CAS  Google Scholar 

  10. Wilson WEC, Kirkpatrick CH, Talmage DW (1965) Suppression of immunologic responsiveness in uraemia. Ann Intern Med 62:1

    Article  Google Scholar 

  11. Vajdic CM, McDonald SP, McCredie MR et al (2006) Cancer incidence before and after kidney transplantation. JAMA 296:2823–2831

    Article  CAS  Google Scholar 

  12. Shebl FM, Warren JL, Eggers PW et al (2012) Cancer risk among elderly persons with end-stage renal disease: a population-based case-control study. BMC Nephrol 13:65

    Article  Google Scholar 

  13. Wong G, Staplin N, Emberson J et al (2016) Chronic kidney disease and the risk of cancer: an individual patient data meta-analysis of 32,057 participants from six prospective studies. BMC Cancer 16:488

    Article  Google Scholar 

  14. Chang WF, Horng HC, Yeh CC et al (2018) Risk of female genital tract related cancers (gynecological cancers) or breast cancer in women with and without chronic kidney disease. A population-based cohort study in Taiwan. Medicine (Baltimore) 97(12):e0157

    Article  Google Scholar 

  15. Chavan DM, Huang Z, Song K et al (2017) Incidence of venous thromboembolism following the neoadjuvant chemotherapy regimen for epithelial type of ovarian cancer. Medicine (Baltimore) 96:e7935

    Article  Google Scholar 

  16. Clarke-Pearson DL (2009) Clinical practice. Screening for ovarian cancer. N Engl J Med 361(2):170–177

    Article  CAS  Google Scholar 

  17. Rule AD (2010) The CKD-EPI equation for estimating GFR from serum creatinine: real improvement or more of the same? Clin J Am Soc Nephrol 5:6951–6953

    Article  Google Scholar 

  18. Creasman W (2009) Revised FIGO staging for carcinoma oft he endometrium. Int J Gynaecol Obstet 105(2):109

    Article  Google Scholar 

  19. Kurman RJ, Carangin ML, Herrington CY et al (2014) WHO Classification of the tumors of the female reproductive organs. World Health Organisation, pp 126, 150

  20. Salani R, Backes FJ, Fung MF et al (2011) Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncologist recommendations. Am J Obstet Gynecol 204(6):466

    Article  Google Scholar 

  21. Croatian Institute of Public Health (2016) The Croatian National Cancer Registry. Cancer incidence in Croatia for 2014. Bulletin No. 39

  22. Donin NM, Suh LK, Barlow L et al (2012) Tumour diameter and decreased preoperative estimated glomerular filtration rate are independently correlated in patients with renal cell carcinoma. BJU Int 109(3):379–383

    Article  CAS  Google Scholar 

  23. Stengel B (2010) Chronic kidney disease and cancer: a troubling connection. J Nephrol 23(3):253–262

    PubMed  PubMed Central  Google Scholar 

  24. Izzedine H, Perazella MA (2015) Onco-nephrology: an appraisal of the cancer and chronic kidney disease links. Nephrol Dial Transplant 30(12):1979–1988

    Article  Google Scholar 

  25. Luo F, Wang YS, Su YH et al (2017) Prognostic implications of preoperative anemia in urothelial carcinoma: a meta-analysis. PLoS One 12(2):e0171701

    Article  Google Scholar 

  26. Premuzic V, Gamulin M, Coric M et al (2017) The incidence of urinary tract cancers is related to preserved diuresis: a single-center report. Int Urol Nephrol 49(12):2257–2263

    Article  Google Scholar 

  27. Espersen T, Schmitz O, Hanse HE et al (1988) Ovulation in uremic women: the reproductive cycle in women on chronic hemodialysis. Int J Fertil 33(2):103–106

    CAS  PubMed  Google Scholar 

  28. Zingraff J, Jungers P, Pelissier C et al (1982) Pituitary and ovarian dysfunctions in women on hemodialysis. Nephron 30(2):149–153

    Article  CAS  Google Scholar 

  29. Ergeneli MH, Duran EH, Zeyneloglu HB et al (1999) Endometrial response to unopposed estrogens remains unaltered in patients with chronic renal failure receiving hemodialysis. Gynecol Obstet Invest 47(1):26–28

    Article  CAS  Google Scholar 

  30. Fucic A, Gamulin M, Ferencic Z et al (2012) Environmental exposure to xenoestrogens and oestrogen related cancers: reproductive system, breast, lung, kidney pancreas, and brain. Environ Health 11(suppl 1):S8

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Vedran Premuzic.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Premuzic, V., Kruezi, E., Berovic, M. et al. The association of the decline in glomerular filtration rate with aggressive endometrial cancers. Int Urol Nephrol 52, 161–168 (2020). https://doi.org/10.1007/s11255-019-02324-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-019-02324-w

Keywords

Navigation